Genetic Department, National Health Institute Doutor Ricardo Jorge (INSARJ), Oporto, Portugal.
Mol Genet Metab. 2013 Jul;109(3):276-81. doi: 10.1016/j.ymgme.2013.04.019. Epub 2013 May 4.
Farber disease, also known as Farber's lipogranulomatosis, is a clinically heterogeneous autosomal recessive disease caused by mutations in the ASAH1 gene. This gene codes for acid ceramidase, a lysosomal heterodimeric enzyme that hydrolyzes ceramide into sphingosine and fatty acid. To date, less than 25 distinct mutations have been identified in Farber patients, but no large deletions have yet been reported. In this work, cultured fibroblasts from a Farber patient with the rare neonatal form of Farber disease were studied to elucidate the molecular basis of this extremely severe phenotype. Direct sequencing of ASAH1 genomic DNA revealed the causative heterozygous mutation in the donor splice site consensus sequence of intron 11, g.24491A > G (c.917 + 4A > G), that resulted in the absence of detectable mRNA. Subsequent analysis of ASAH1 mRNA showed total skipping of exons 3 to 5. Long-range PCR and sequencing led to the identification of a gross deletion of ASAH1 gene, g.8728_18197del (c.126-3941_382 + 1358del) predicting the synthesis of a truncated polypeptide, p.Tyr42_Leu127delinsArgfs*10. Accordingly, no molecular forms corresponding to precursor or proteolytically processed mature protein were observed. These findings indicate that any functionally active acid ceramidase is absent in patient cells, underscoring the severity of the clinical phenotype. Molecular findings in the non-consanguineous parents confirmed the compound heterozygous ASAH1 genotype identified in this Farber case. This work unravels for the first time the mutations underlying the neonatal form of Farber disease and represents the first report of a large deletion identified in the ASAH1 gene. Screening for gross deletions in other patients in whom the mutation present in the second allele had not yet been identified is required to elucidate further its overall contribution for the molecular pathogenesis of this devastating disease.
法伯病,又称法伯脂肉芽肿病,是一种由 ASAH1 基因突变引起的临床异质性常染色体隐性遗传病。该基因编码酸性鞘磷脂酶,这是一种溶酶体异二聚体酶,可将神经酰胺水解为神经鞘氨醇和脂肪酸。迄今为止,在法伯病患者中已发现不到 25 种不同的突变,但尚未报道大片段缺失。在这项工作中,研究了来自患有罕见新生儿型法伯病的法伯病患者的培养成纤维细胞,以阐明这种极其严重表型的分子基础。对 ASAH1 基因组 DNA 的直接测序揭示了供体位点剪接共识序列中的杂合突变,g.24491A > G(c.917 + 4A > G),导致可检测的 mRNA 缺失。随后对 ASAH1 mRNA 的分析显示外显子 3 至 5 完全缺失。长距离 PCR 和测序导致鉴定出 ASAH1 基因的大片段缺失,g.8728_18197del(c.126-3941_382 + 1358del),预测合成截断多肽,p.Tyr42_Leu127delinsArgfs*10。因此,没有观察到与前体或蛋白水解加工成熟蛋白相对应的分子形式。这些发现表明患者细胞中不存在任何具有功能活性的酸性鞘磷脂酶,突出了临床表型的严重性。非近亲父母的分子发现证实了该法伯病病例中鉴定的复合杂合 ASAH1 基因型。这项工作首次揭示了新生儿型法伯病的突变基础,并代表了首次报道在 ASAH1 基因中发现的大片段缺失。需要对其他患者进行大片段缺失筛查,这些患者的第二个等位基因突变尚未确定,以进一步阐明其对这种毁灭性疾病分子发病机制的总体贡献。